Madrigal Pharmaceuticals, Inc. (MDGL) quarterly cash flow statement — complete operating, investing & financing history
Madrigal Pharmaceuticals, Inc. (MDGL) cash flow statement — 23-year operating, investing & financing cash flows
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Cash from Operations | 120.56M | 23.33M | -167.44M | -133.46M | 79.85M | -47.05M | -88.89M | -104.49M | -66.98M | -134.94M | -149.16M | -79.93M | -84.92M | -75.31M | -84.07M | -58.52M | -59.07M | -57.36M | -49.91M | -48.05M |
| Operating CF Margin % | 27.95% | 6.4% | -53.78% | -41.57% | 27.8% | -22.11% | -64.77% | -101.13% | -107.73% | -921.88% | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 50.98% | 149.58% | -88.36% | -27.73% | 219.21% | 65.13% | 40.4% | -30.72% | 21.12% | -79.19% | -77.43% | -36.6% | -43.76% | -31.29% | -68.43% | -21.78% | -29.66% | -22.35% | -14.93% | 12.55% |
| Net Income | 55.44M | -57.94M | -94.39M | -58.58M | -114.19M | -42.28M | -73.24M | -59.42M | -106.96M | -151.97M | -147.54M | -112.19M | -98.74M | -85.8M | -76.9M | -85.91M | -81.2M | -70.73M | -57.52M | -64.55M |
| Depreciation & Amortization | 391K | 381K | 386K | 392K | 358K | 377K | 379K | 363K | 298K | 267K | 168K | 142K | 135K | 126K | 124K | 129K | 121K | 110K | 107K | 106K |
| Stock-Based Compensation | 38.95M | 35.37M | 34.02M | 0 | 26.25M | 25.16M | 20.93M | 17.68M | 17.9M | 24.4M | 19.9M | 14.85M | 12.66M | 10.97M | 11.25M | 8.08M | 8.12M | 7.94M | 7.48M | 6.36M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -30.65M |
| Other Non-Cash Items | -655K | 72.62M | -1.58M | 27.19M | 4.33M | 1.37M | 492K | 540K | 22K | 472K | 655K | 753K | 674K | 554K | 433K | 306K | 313K | 178K | 0 | 30.65M |
| Working Capital Changes | 26.43M | -27.1M | -105.86M | -102.47M | 163.1M | -31.68M | -37.45M | -63.65M | 21.76M | -8.12M | -22.34M | 16.51M | 351K | -1.16M | -18.98M | 18.87M | 13.57M | 5.14M | 21K | 10.04M |
| Change in Receivables | -35.09M | -4.96M | -52.88M | -21.19M | -34.05M | -17.8M | -7.61M | -23.36M | -23.56M | -6.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | -25.15M | -11.46M | -22.19M | -1.73M | -5.82M | -8.26M | -21.17M | -25.35M | -1.64M | -6.22M | -854K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 29.42M | -21.14M | 3.58M | 4.94M | 5.96M | -4.08M | -1.54M | -2.37M | 36.97M | -7.53M | -11.51M | 11.5M | -992K | 5.41M | -11.7M | 5.27M | 7.27M | -11.49M | 1.4M | 10.96M |
| Cash from Investing | 93.79M | 34.2M | 192.19M | 27.58M | -207M | 47.86M | 163.88M | -47.95M | -202.39M | -122.1M | 98.05M | -362.12M | 50.2M | -3.73M | -186.86M | 66.39M | 65.14M | 19.24M | 55.93M | 15.64M |
| Capital Expenditures | -3.93M | -4.25M | -3.85M | 390K | -3.86M | 0 | 0 | -195K | -779K | -131K | -357K | -1.04M | -339K | -69K | -35K | -29K | -33K | -103K | -52K | -113K |
| CapEx % of Revenue | 0.91% | 1.17% | 1.24% | 0.12% | 1.34% | - | - | 0.19% | 1.25% | 0.89% | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -50.54K | 0 | 0 | -3K | -65.17K | -19.34K | 0 | 787K |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -2.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5M | 0 | 0 | 50.54K | 0 | 0 | 3K | 65.17K | 19.34K | 0 | -787K |
| Cash from Financing | 9.96M | 3.11M | 2.33M | 8.96M | 236.65M | 1.74M | 8.64M | 19.77M | 7.46M | 134.12M | 573.71M | 479.92M | 19.58M | 42.93M | 52.69M | 264.34M | 0 | 49.11M | 0 | 19.5M |
| Debt Issued (Net) | 0 | 0 | 0 | -983K | 218.91M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15M | 15M | 35M | 0 | 0 | 50M | 0 | 0 |
| Equity Issued (Net) | 9.96M | 3.11M | 2.33M | 9.94M | 17.73M | -8.64M | 8.64M | 19.77M | 7.46M | 85.95M | 311.56M | 235.7M | 2.73M | 21.75M | 0 | 255.38M | 0 | 0 | 0 | 18.96M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 10.38M | 0 | 0 | 0 | 48.17M | 262.14M | 244.21M | 1.85M | 6.18M | 17.69M | 8.96M | 0 | -886K | 0 | 545K |
| Net Change in Cash | 222.57M | 60.69M | 28.41M | -96.91M | 109.5M | 2.55M | 83.63M | -132.66M | -261.91M | -122.92M | 522.6M | 37.86M | -15.14M | -36.11M | -218.24M | 272.21M | 6.07M | 10.99M | 6.01M | -12.9M |
| Free Cash Flow | 116.63M | 19.08M | -171.28M | -133.07M | 78.99M | -47.05M | -88.89M | -104.68M | -67.76M | -140.08M | -149.51M | -80.97M | -85.26M | -75.38M | -84.1M | -58.54M | -59.1M | -57.46M | -49.97M | -48.16M |
| FCF Margin % | 27.04% | 5.24% | -55.02% | -41.44% | 27.5% | -22.11% | -64.77% | -101.32% | -108.99% | -956.93% | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 47.64% | 140.54% | -92.69% | -27.12% | 216.57% | 66.41% | 40.55% | -29.29% | 20.52% | -85.83% | -77.78% | -38.3% | -44.26% | -31.18% | -68.32% | -21.55% | -29.59% | -22.57% | -14.93% | 12.36% |
| FCF per Share | 3.85 | 0.65 | -5.90 | -5.93 | 3.51 | -2.12 | -4.02 | -4.77 | -3.12 | -6.54 | -7.47 | -4.10 | -4.61 | -4.12 | -4.62 | -3.40 | -3.46 | -3.36 | -2.92 | -2.82 |
| FCF Conversion (FCF/Net Income) | 2.17x | -0.40x | 1.77x | 2.28x | -0.70x | 1.11x | 1.21x | 1.76x | 0.63x | 0.89x | 1.01x | 0.71x | 0.86x | 0.88x | 1.09x | 0.68x | 0.73x | 0.81x | 0.87x | 0.74x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |